Rockville (MD), August 4, 2017 —
The search for test results that can be useful during or shortly after a physician/patient consult has long been the goal of healthcare providers and the testing industry, and was a notable focus of the largest meeting of lab professionals and IVD firms this year. This is according to healthcare market research firm Kalorama Information. The firm said scores of companies with point of care testing (POCT) offerings or related supplies and software were at the American Association for Clinical Chemistry Meeting in San Diego, CA.
Kalorama Information covers Point of Care testing markets in its report Top 50 Companies in Point of Care Diagnostic Tests..
"Recent developments in nucleic acid POC technology and in fluidics, costs, more skilled manufacturing all have combined to make a more convincing case for these technologies," said Bruce Carlson, Publisher of Kalorama Information, who was at the meeting. "Significant IVD vendors have launched systems."
Among the significant point of care developments noted by Kalorama Information:
- Siemens Healthineers launched its Xprecia Stride Coagulation Analyzer. The handheld testing fingerprick device has a large, intuitive touchscreen on the handle. PT/INR testing is used for the monitoring of oral anticoagulation therapy (OAT) with warfarin. The company says the unit provides lab accuracy and intergrates with EHR though Siemens-owned UniPOC Software.
- Trinity Biotech promoted its Syphilis Health Check. The company claims the product is the only CLIA waived rapid screening product for the disease. This product can be used as an initial screening test or in conjunction with a non-treponemal laboratory test and clinical findings to aid in the diagnosis of syphilis infection.
- Sarstedt showcased its S-Monovette POC Collect Kit. The system is an innovative, point of care collection system for venous sampling, designed to be easy to use but yet precise enough to avoid risking blood exposure.
- Roche Diagnostics CoaguCheck XS Plus System delivered CLIA-waived testing with enhanced connectivity. Also on display was the company's cobas Liat, an automated multiplex real-time RT-PCR assay for the rapid in vitro qualitative detection and discrimination of Influenza A virus and Influenza B virus RNA in nasopharyngeal swab specimens The test is intended for use as an aid in the differential diagnosis of Influenza A, Influenza B, and RSV and is aimed at POLs and small clinics.
- Alere Afinion's AS100 Analyzer can provide CLIA-Waived A1C results in 3 minutes and Albumin/Creatinine Ratio) results in 5 minutes. The test is s used to screen people with chronic conditions, such as diabetes and high blood pressure (hypertension) that put them at an increased risk of developing kidney disease.
- Orchard Software launched its Orchard Trellis, a POC testing information system that the company says simplifies the integration, administration, and management of point-of-care testing (POCT). POCT results are integrated into the EHR, promoting fast access and making results available for population health management. Status of POCT sites (instruments, user certifications, QC, patient result statuses) can be quickly assessed via an information dashboard, and result evaluation rules functionality, Levey-Jennings QC graphs, and linearity reports are offered.
- The epoc Blood Analysis system delivers blood gas and electrolyte results in about 30 seconds, according to the manufacturer. Currently part of Alere, Siemens Healthineers recently announced its intention to buy the unit that owns epoc due to Alere's merger with Abbott. Abbot's iStat blood gas POC system was also on display at the meeting.
- A palm sized dock and disposable assay speific test cassettes were a feature of Mesa Biotech's Accula System. The San Diego-based company says its MDX-POC system will allow healthcare professionals to access actionable, laboratory-quality results at the POC in 30 minutes or less with greater sensitivity and specificity than many current infectious disease rapid immunodiagnostic tests.
• DiaSorin showcased the firm's Simplex C. difficile Direct Assay for marketing in the US. The test runs on DiaSorin's Liaison MDX benchtop instrument, which provides clinically validated, real-time PCR results t about 15,000 C. difficile-related deaths occur in the US annually, and added that the bacteria is the most common microbial cause of US hospital-associated infections. The assay has been available outside the US since November.
Other companies with POC test-related offerings at AACC 2017 in San Diego included:
- Sekisui Diagnostics
- BioREF Gmbh
- Alfa Scientific Designs
- DxGen Corp.
- Nova Biomedical
- Trinity Biotech
- SK Telecom
- MP Biomedicals
- Atlas Scientific
- Access Bio
- Edan Instruments
- DAAN Gene
- Helena Laboratories
- Beckman Coulter
- Meridian Bioscience
- Quidel Corporation
Kalorama Information covers Point of Care testing markets in its report Top 50 Companies in Point of Care Diagnostic Tests available at: https://www.kaloramainformation.com/Companies-Point-Care-10828861/.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama’s website and are also available on www.marketresearch.com and www.profound.com.
We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.
Please link any media or news references to our reports or data to http://www.kaloramainformation.com/.